Rejuvitas, Inc.
New York, US · Founded 2021 · Delaware corporation · 1 known investors
Founders & leadership
AS
Andrea SpezziNamed on SEC filing
Board
JP
John PrufetainBoard directorChief Executive Officer and Managing Partner at Medical Excellence Capital
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.3M disclosed across 2 rounds · 2021–2022
▶$5MraisedSep 2022 · 3 investors · BiotechnologyRule 506(b)
▶$5MraisedSep 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrea SpezziExecutive Officer, Director
- John PrufetaDirector
- Eric HeilDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.3MraisedJan 2022 · 3 investors · BiotechnologyRule 506(b)
▶$3.3MraisedJan 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joni ManciniExecutive Officer
- Andrea SpezziExecutive Officer, Director
- Eric HeilDirector
- John PrufetaDirector
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Rejuvitas, Inc.'s investors?
- Rejuvitas, Inc.'s investors include Medical Excellence Capital.
- How much funding has Rejuvitas, Inc. raised?
- Rejuvitas, Inc. has disclosed $8.3M raised across 2 rounds.
- Where is Rejuvitas, Inc. headquartered?
- Rejuvitas, Inc. is headquartered in New York, US.